000			03601nam a22004335i 4500
001			978-1-59259-941-7
003			DE-He213
005			20161121230556.0
007			cr nn 008mamaa
008			100301s2005 xxu| s |||| 0|eng d
020			_a9781592599417 _9978-1-59259-941-7
024	7		_a10.1385/1592599419 _2doi
050		4	_aRC681-688.2
072		7	_aMJD _2bicssc
072		7	_aMED010000 _2bisacsh
082	0	4	_a616.12 _223
245	1	0	_aCardiovascular Disease in the Elderly _h[electronic resource] / _cedited by Gary Gerstenblith.
264		1	_aTotowa, NJ : _bHumana Press, _c2005.
300			_bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aContemporary Cardiology
505	0		_aAging of the Heart and Arteries -- Frailty -- Cardiovascular Risk Factors in the Elderly -- Stable Coronary Artery Disease in the Elderly -- Age and Mortality and Morbidity in ST-Segment Elevation Myocardial Infarction -- Unstable Angina/Non-ST-Elevation Myocardial Infarction in the Elderly -- Percutaneous Coronary Intervention in the Elderly -- Cardiac Surgery in the Elderly -- Heart Failure in the Elderly -- Valvular Heart Disease in the Elderly -- Arrhythmia Management in the Elderly -- Peripheral Arterial Disease in the Elderly -- Cardiac Rehabilitation in Older Cardiac Patients -- Clinical Pharmacology -- Medical Treatment of the Cardiac Patient Approaching the End of Life.
520			_aAs the number, availability, and often the invasiveness and associated risks of new cardiovascular treatments expands, health care providers are increasingly called upon to decide whether or not to recommend these therapies to the increasing numbers of older patients with cardiovascular disease. In Cardiovascular Disease in the Elderly, a panel of clinicians, researchers, and leaders in the field review and discuss the latest findings on the pathophysiology, diagnosis, and management of cardiovascular disease in the older patient. The authors explain the physiological changes associated with the normal aging process that may lead to the development of disease, to adverse consequences once disease develops, and which alter the risk-benefit equation for medical and other interventions designed to diagnose, assess, and treat cardiovascular disease. The focus is on particularly common syndromes in the elderly, including cardiac failure with normal ejection fraction, isolated systolic hypertension, and atrial fibrillation. Wherever possible, the authors take an evidence-based approach to recommendations and rely heavily on prospective clinical trials. The value of lifestyle changes in the aging population, the use of primary and secondary prevention strategies, and the treatment of acute and chronic ischemic disease and its complications are also discussed. Comprehensive and authoritative, Cardiovascular Disease in the Elderly offers physicians and other providers who care for the older patient a gold-standard approach to understanding and managing cardiovascular disease in this group.
650		0	_aMedicine.
650		0	_aCardiology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aCardiology.
700	1		_aGerstenblith, Gary. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781588292827
830		0	_aContemporary Cardiology
856	4	0	_uhttp://dx.doi.org/10.1385/1592599419
912			_aZDB-2-SME
950			_aMedicine (Springer-11650)
999			_c500796 _d500796